1. Home
  2. XBIT vs XTNT Comparison

XBIT vs XTNT Comparison

Compare XBIT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.19

Market Cap

70.1M

Sector

Health Care

ML Signal

N/A

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

N/A

Current Price

$0.32

Market Cap

61.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
XTNT
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.1M
61.7M
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
XBIT
XTNT
Price
$2.19
$0.32
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
43.4K
2.9M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.00
EPS
N/A
N/A
Revenue
N/A
$53,337,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$0.27
52 Week High
$3.44
$0.95

Technical Indicators

Market Signals
Indicator
XBIT
XTNT
Relative Strength Index (RSI) 42.69 39.38
Support Level $2.19 $0.27
Resistance Level $2.46 $0.47
Average True Range (ATR) 0.05 0.05
MACD -0.01 -0.00
Stochastic Oscillator 25.00 4.60

Price Performance

Historical Comparison
XBIT
XTNT

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Share on Social Networks: